NHL and Sjögren’s syndromeBCL2 (NHL) and IRF5 (Sjögren’s Syndrome) a potential cross-pathway interaction is suggested by the connection between BCL2’s role in apoptotic control in NHL and IRF5’s role in the immunological response in Sjögren’s syndrome. This evidence concerns the gene IRF5 and Sjogren syndrome.